Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Engaging Patients in Clinical Trial Planning: Exploring the Concept of a Minimal Clinically Important Difference Among Patients with Obstetrical Antiphospholipid Syndrome

Leslie Skeith, MD, Taryn S. Taylor, MD PhD, Shannon M. Bates, MD MSc, Lisa D. Duffett, MD, Robert M. Silver, MD, Marc A. Rodger, MD MSc

Blood (2018) 132 (Supplement 1): 4723.

https://doi.org/10.1182/blood-2018-99-117738

Published: 2018

Journal Articles

"Part of the Ritual": a Qualitative Study of Patient and Physician Perspectives on the Use of Anticoagulation for Improving Pregnancy Outcomes in Obstetrical Antiphospholipid Syndrome

Leslie Skeith, MD, Marc A. Rodger, MD MSc, Shannon M. Bates, MD MSc, Carol Gonsalves, MD MMEd, Taryn S. Taylor, MD PhD

Blood (2018) 132 (Supplement 1): 5804.

https://doi.org/10.1182/blood-2018-99-117677

Published: 2018

Journal Articles

Referral for Thrombophilia Testing in an Obstetric Patient Population: A Tertiary Centre Experience

Ayesha Ejaz, Helen Moore

Blood (2017) 130 (Supplement 1): 5597.

https://doi.org/10.1182/blood.V130.Suppl_1.5597.5597

Published: 2017

Journal Articles

Is Homozygosity for the MTHFR C677T Mutation a Risk Factor for Miscarriage? — Likely.

Ivy Altomare, MD, Louis M. Aledort, MD

Blood (2006) 108 (11): 4079.

https://doi.org/10.1182/blood.V108.11.4079.4079

Published: 2006

Journal Articles

The Effect of Dalteparin on Coagulation Activation during Pregnancy in Women with Thrombophilia: A Randomised Trial.

Karim Abou-Nassar, MD, Marc Rodger, MD, Michael J. Kovacs, MD, Steve Doucette, MSc, Ramsay Tim, PhD, Susan Kahn, MD, Philip Wells, MD, Katherine Sue Robinson, MD, Mark Blostein, MD, Susan Solymoss, MD, Evelyne Rey, MD

Blood (2006) 108 (11): 874.

https://doi.org/10.1182/blood.V108.11.874.874

Published: 2006

Journal Articles

Prophylactic Low Molecular Weight Heparin (LMWH) during Pregnancy Is Not Associated with a Decrease in Bone Mineral Density (BMD). The TIPPS (Thrombophilia in Pregnancy Prophylaxis Study) BMD Substudy.

Marc A. Rodger, MD, MSc, Alejandro Lazo-Langner, MD, Susan Kahn, MD, MSc, Michael Kovacs, MD, Sue Robinson, MD, Mark Blostein, MD, Graeme Smith, MD, John Kingdom, MD, Christine Demers, MD, Susan Solymoss, MD, Rshmi Khurana, MD, Evelyn Rey, MD, Anne Marie Clement, RN, Philip S. Wells, MD, MSc

Blood (2005) 106 (11): 548.

https://doi.org/10.1182/blood.V106.11.548.548

Published: 2005

NARROW

Engaging Patients in Clinical Trial Planning: Exploring the Concept of a Minimal Clinically Important Difference Among Patients with Obstetrical Antiphospholipid Syndrome

"Part of the Ritual": a Qualitative Study of Patient and Physician Perspectives on the Use of Anticoagulation for Improving Pregnancy Outcomes in Obstetrical Antiphospholipid Syndrome

Referral for Thrombophilia Testing in an Obstetric Patient Population: A Tertiary Centre Experience

Is Homozygosity for the MTHFR C677T Mutation a Risk Factor for Miscarriage? — Likely.

The Effect of Dalteparin on Coagulation Activation during Pregnancy in Women with Thrombophilia: A Randomised Trial.

Prophylactic Low Molecular Weight Heparin (LMWH) during Pregnancy Is Not Associated with a Decrease in Bone Mineral Density (BMD). The TIPPS (Thrombophilia in Pregnancy Prophylaxis Study) BMD Substudy.

Email alerts

ASH Publications

American Society of Hematology

Engaging Patients in Clinical Trial Planning: Exploring the Concept of a Minimal Clinically Important Difference Among Patients with Obstetrical Antiphospholipid Syndrome

"Part of the Ritual": a Qualitative Study of Patient and Physician Perspectives on the Use of Anticoagulation for Improving Pregnancy Outcomes in Obstetrical Antiphospholipid Syndrome

Referral for Thrombophilia Testing in an Obstetric Patient Population: A Tertiary Centre Experience

Is Homozygosity for the MTHFR C677T Mutation a Risk Factor for Miscarriage? — Likely.

The Effect of Dalteparin on Coagulation Activation during Pregnancy in Women with Thrombophilia: A Randomised Trial.

Prophylactic Low Molecular Weight Heparin (LMWH) during Pregnancy Is Not Associated with a Decrease in Bone Mineral Density (BMD). The TIPPS (Thrombophilia in Pregnancy Prophylaxis Study) BMD Substudy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only